|
Post by brotherm1 on Nov 7, 2017 15:20:35 GMT -5
MannKind Corporation to Hold 2017 Third Quarter Financial Results Conference Call on November 7, 2017 WESTLAKE VILLAGE, Calif., Oct. 27, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) (MNKD) will release its 2017 third quarter financial results on Tuesday, November 7, 2017 and its management will host a conference call to discuss the third quarter financial results and other Company developments at 5:00 PM (Eastern Time) on November 7, 2017. Presenting from the Company will be its Chief Executive Officer, Michael Castagna, Chief Financial Officer, Steven Binder, and Chief Commercial Officer, Pat McCauley. To participate in the live call by telephone, please dial (888) 771-4371 or (847) 585-4405 and use the participant passcode: 44096374. Those interested in listening to the conference call live via the Internet may do so by visiting investors.mannkindcorp.com/events.cfm?EventType=WebcastA telephone replay of the call will be accessible for approximately 14 days following completion of the call by dialing (888) 843-7419 or (630) 652-3042 and use the participant passcode: 4409 6374#. A replay will also be available on MannKind's website for 14 days.
|
|
|
Post by madog365 on Nov 7, 2017 15:48:44 GMT -5
Really excited to hear what MNKD has in store for us
|
|
|
Post by kite on Nov 7, 2017 15:50:52 GMT -5
haha I am excited too!
|
|
|
Post by kc on Nov 7, 2017 15:56:06 GMT -5
I got so excited that I added a few more shares. That dam 10 step program never works for me.
Seems that the company has enough cash runway now based on the 3 quarter information.
Cash and Cash Equivalents
Cash and cash equivalents at September 30, 2017 decreased to $20.1 million from $43.4 million at June 30, 2017, primarily due to cash burn for the third quarter of 2017 of $23.3 million. The cash balance as of September 30, 2017 does not include $57.7 million of net proceeds received from the registered direct offering of the Company’s common stock completed in October 2017.
77.8 million on hand.
|
|
|
Post by winner on Nov 7, 2017 16:14:37 GMT -5
Fingers and toes crossed. Hey, it may help. Not selling until >$20.00 a share.......... I love it.........
|
|
|
Post by kite on Nov 7, 2017 16:18:43 GMT -5
I got so excited that I added a few more shares. That dam 10 step program never works for me.
Seems that the company has enough cash runway now based on the 3 quarter information.
Cash and Cash Equivalents
Cash and cash equivalents at September 30, 2017 decreased to $20.1 million from $43.4 million at June 30, 2017, primarily due to cash burn for the third quarter of 2017 of $23.3 million. The cash balance as of September 30, 2017 does not include $57.7 million of net proceeds received from the registered direct offering of the Company’s common stock completed in October 2017.
77.8 million on hand.
I am more excited about what is ahead in the New Year and that we have the funds to keep moving forward
|
|
|
Post by peppy on Nov 7, 2017 16:43:06 GMT -5
|
|
|
Post by mango on Nov 7, 2017 16:44:43 GMT -5
I hope Mike gives an update on RLS.
|
|
|
Post by ilovekauai on Nov 7, 2017 16:44:47 GMT -5
Kite: Now that was funny about the "10 Step Program." LoL!
|
|
|
Post by awesomo on Nov 7, 2017 16:44:55 GMT -5
I'm guessing traders are waiting for the actual call. If the team doesn't say anything new, shorts are going to have a field day.
|
|
|
Post by mango on Nov 7, 2017 16:53:00 GMT -5
I'm guessing traders are waiting for the actual call. If the team doesn't say anything new, shorts are going to have a field day. MannKind has three clinical trials in progress right now, a positive label change, continuous increase in scripts, and has the only insulin in the world that can restore glucose homeostasis. You'd have to have the thinking of the ADA to short this company.
|
|
|
Post by dreamboatcruise on Nov 7, 2017 17:03:04 GMT -5
I'm guessing traders are waiting for the actual call. If the team doesn't say anything new, shorts are going to have a field day. Yeah, they'd better have something to say in light of wanting to double shares.
|
|
|
Post by peppy on Nov 7, 2017 18:03:48 GMT -5
alrighty then
|
|
|
Post by mytakeonit on Nov 7, 2017 18:05:51 GMT -5
Mike still didn't mention snorting Afrezza
|
|
|
Post by joeypotsandpans on Nov 7, 2017 18:06:57 GMT -5
Mike's my hero, not sure how he landed on our shores but both as a PWD and an investor, thank you lord.
|
|